近5日资金流向一览见下表： | 日期 | | | | | 收盘价 涨跌幅 主力净流入 主力净占比 游资净占比 散户净流入 散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-26 | 23.35 -0.34% | | 144.45万 | 3.18% | -629.94万 | -13.89% | 485.50万 | - 10.70% | | 2025-08-25 | 23.43 -0.93% | | -579.47万 | -11.78% | 611.60万 | 12.43% | -32.14万 | -0.65% | | 2025-08-22 | 23.65 -0.50% | | 561.75万 | 9.26% | -247.28万 | -4.08% | -314.47万 | -5.18% | | 2025-08-21 | 23.77 | 0.21% | -280.59万 | -4.93% | -3.18万 | -0.06% | 283.77万 | 4.98% | | 2025-08-20 | 23.72 ...

来源：新浪证券-红岸工作室 资料显示，四川港通医疗设备集团股份有限公司位于四川省成都市简阳市凯力威工业大道南段356号， 成立日期1998年1月13日，上市日期2023年7月25日，公司主营业务涉及为医疗机构提供以医用气体系统 及医院洁净手术部为核心的医疗专业工程整体方案。主营业务收入构成为：医用洁净装备及系统 65.42%，医用气体装备及系统29.43%，医疗设备及其他产品销售3.01%，运维服务1.85%，其他(补 充)0.30%。 8月22日，港通医疗跌0.50%，成交额6065.51万元。两融数据显示，当日港通医疗获融资买入额578.96 万元，融资偿还402.56万元，融资净买入176.41万元。截至8月22日，港通医疗融资融券余额合计 5841.73万元。 截至8月20日，港通医疗股东户数8690.00，较上期减少8.23%；人均流通股7327股，较上期增加8.96%。 2025年1月-3月，港通医疗实现营业收入2428.67万元，同比减少68.09%；归母净利润157.90万元，同比 减少85.25%。 融资方面，港通医疗当日融资买入578.96万元。当前融资余额5841.73万元，占流通市值的 ...

证券日报网讯 8月22日晚间，港通医疗发布公告称，公司的全资子公司港通通用设备制造（成都）有限 公司根据公司总体战略规划和布局安排，为满足未来的业务发展需要，对其企业经营范围进行了变更， 相关工商变更登记手续已于近日办理完毕，并取得了四川省简阳市行政审批局换发的《营业执照》。 （编辑 李家琪） ...

证券代码：301515 证券简称：港通医疗 公告编号：2025-047 公司名称：港通通用设备制造（成都）有限公司 统一社会信用代码：91510185752337597M 类型：有限责任公司（外商投资企业法人独资） 法定代表人：陈永 四川港通医疗设备集团股份有限公司 关于子公司变更经营范围暨完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）的全资子公司港 通通用设备制造（成都）有限公司根据公司总体战略规划和布局安排，为满足未 来的业务发展需要，对其企业经营范围进行了变更，相关工商变更登记手续已于 近日办理完毕，并取得了四川省简阳市行政审批局换发的《营业执照》，主要情 况如下： 变更内容 变更前 变更后 经营范围 一般项目：通用设备制造（不含特 种设备制造）；专用设备制造（不 含许可类专业设备制造）；通用零 部件制造；机械零件、零部件加工； 机械电气设备制造；家具制造；机 械设备研发；金属制品研发；机械 设备销售；金属制品销售；机械电 气设备销售；家具销售。（除依法 须经批准的项目外，凭营 ...

Company Overview - Sichuan Portong Medical Equipment Group Co., Ltd. is located at 356, South Section of Kailiwei Industrial Avenue, Jianyang, Chengdu, Sichuan Province, established on January 13, 1998, and listed on July 25, 2023 [2] - The company primarily provides medical institutions with medical devices and equipment [2] Stock Performance - As of August 22, Portong Medical's stock price decreased by 2.02%, trading at 23.29 CNY per share, with a total market capitalization of 2.329 billion CNY [1] - Year-to-date, the stock price has increased by 30.37%, with a slight decline of 0.98% over the last five trading days, a 3.33% increase over the last 20 days, and a 19.41% increase over the last 60 days [2] Financial Metrics - As of August 20, the number of shareholders for Portong Medical was 8,690, a decrease of 8.23% from the previous period, with an average of 7,327 circulating shares per shareholder, an increase of 8.96% [2] - For the first quarter of 2025, the company reported a revenue of 24.2867 million CNY, a year-on-year decrease of 68.09% [2] - Since its A-share listing, Portong Medical has distributed a total of 48.9973 million CNY in dividends [2] Market Activity - The net outflow of main funds was 557,800 CNY, with no significant large orders purchased, while large orders bought amounted to 2.9041 million CNY and sold 2.4607 million CNY [1]

Core Viewpoint - As of August 20, 2025, the stock price of Porton Medical (301515) closed at 23.72 yuan, reflecting a decrease of 0.55% with a turnover rate of 4.15% and a trading volume of 26,400 shares, amounting to a transaction value of 62.26 million yuan [1]. Group 1: Company Operations - The company specializes in providing medical gas equipment and systems, as well as medical clean equipment and systems, aimed at addressing medical gas supply and infection issues [1]. - The company's products are primarily utilized in hospital wards, operating rooms, ICUs, central supply rooms, various laboratories, and high-altitude diffusion oxygen scenarios [1]. - The company's clean equipment and systems technology can be applied to data centers and laboratories for clean processing, although it has not yet been applied to liquid-cooled servers [1]. Group 2: Market Activity - On August 20, the net outflow of main funds from Porton Medical was 1.44 million yuan, while retail investors saw a net inflow of 1.47 million yuan [2]. - The trading data indicates that speculative funds experienced a net outflow of 27,200 yuan on the same day [2].

Core Viewpoint - 港通医疗's stock closed at 23.30 yuan on August 18, experiencing a decline of 0.22 yuan from the previous trading day, with a trading volume of 1.01 billion yuan and a turnover rate of 6.77% [1] Group 1: Company Overview - 港通医疗 specializes in the research and production of medical gas equipment and systems, as well as medical clean equipment and systems, primarily used in hospital wards and operating rooms [1] - The company's products are a crucial part of smart hospital construction [1] Group 2: Recent Developments - 港通医疗 has not yet initiated business in clean medical warehouse robots or fertility robots, nor has it established business relations with brain-machine equipment companies [1] - The company is focused on monitoring advancements in AI medical technology to enhance product intelligence and meet the modernization needs of hospitals [1] Group 3: Financial Performance - The stock's current price-to-earnings ratio is 368.92 times, and the price-to-book ratio is 1.88 times [1] - On August 18, the main funds experienced a net outflow of 12.40 million yuan, with a cumulative net outflow of 8.71 million yuan over the past five trading days [2]

风险提示：股市有风险，投资需谨慎。 来源：金融界 该公司属于医疗器械行业，主营业务涵盖医疗专业工程设计与施工、医疗设备研发制造等领域。作为四 川地区企业，港通医疗具有专精特新企业资质，并涉及医废处理等业务方向。 资金流向方面，港通医疗8月15日主力资金净流入376.63万元，近五个交易日累计净流入479.62万元。当 前流通市值为14.98亿元，总市值23.52亿元。 港通医疗8月15日报收23.52元，较前一交易日下跌0.06元，跌幅0.25%。当日开盘价为23.56元，最高触 及24.40元，最低下探23.30元，全天振幅达4.66%。盘中曾出现快速反弹，9点35分时股价报24.07元，5 分钟内涨幅超过2%，成交金额达1139.77万元。 ...

证券之星消息，截至2025年8月14日收盘，港通医疗(301515)报收于23.58元，下跌1.34%，换手率 7.92%，成交量5.05万手，成交额1.19亿元。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 该股主要指标及行业内排名如下： | 指标 | 港通医疗 | 医疗器械行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 23.58亿元 | 117.92亿元 | 118 123 | | 净资产 | 12.48亿元 | 38.99亿元 | 98 123 | | 净利润 | 157.9万元 | 7941.99万元 | 99 123 | | 市盈率(动) | 373.35 | 64.88 | 95 123 | | 市净率 | 1.91 | 3 ...

Group 1 - The core point of the article highlights the financing activities of Kangtong Medical, which had a financing buy-in amount of 0.15 billion yuan on August 11, ranking 2087 in the market [1] - Over the last three trading days from August 7 to August 11, Kangtong Medical received financing buy-ins of 0.08 billion yuan, 0.17 billion yuan, and 0.15 billion yuan respectively [1] - On the same day, the company had a financing repayment amount of 0.11 billion yuan, resulting in a net buy of 4.1457 million yuan [1] Group 2 - In terms of securities lending, there were no shares sold or net sold on that day, indicating no activity in this area for Kangtong Medical [2]